IL7R and arthritic joint disease: To target these remaining cells, we developed an alternative IL-7R-targeting ADC for the treatment of steroid-resistant arthritis using monomethyl auristatin E (MMAE)39, 40 as a payload due to its more potent cytotoxicity compared to that of SN-38.